Corcept Therapeutics (CORT) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Corcept Therapeutics | 7.26 Bn | 6.92 Bn | 162.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.73% |
| Dec 31, 2025 | 9.60% |
| Sep 30, 2025 | 32.57% |
| Jun 30, 2025 | 11.91% |
| Mar 31, 2025 | 1.23% |
| Dec 31, 2024 | 32.49% |
| Sep 30, 2024 | 25.02% |
| Jun 30, 2024 | 17.20% |
| Mar 31, 2024 | 24.71% |
| Dec 31, 2023 | 26.63% |
| Sep 30, 2023 | 26.96% |
| Jun 30, 2023 | 40.79% |
| Mar 31, 2023 | 55.38% |
| Dec 31, 2022 | 16.38% |
| Sep 30, 2022 | 10.10% |
| Jun 30, 2022 | 1.00% |
| Mar 31, 2022 | 10.25% |
| Dec 31, 2021 | 8.53% |
| Sep 30, 2021 | 14.62% |
| Jun 30, 2021 | 17.96% |
| Mar 31, 2021 | 5.15% |
| Dec 31, 2020 | 13.51% |
| Sep 30, 2020 | -3.46% |
| Jun 30, 2020 | 9.58% |
| Mar 31, 2020 | 17.35% |
| Dec 31, 2019 | 5.22% |
| Sep 30, 2019 | 10.91% |
| Jun 30, 2019 | 11.34% |
| Mar 31, 2019 | 2.62% |
| Dec 31, 2018 | -5.38% |
| Sep 30, 2018 | -11.71% |
| Jun 30, 2018 | -15.47% |
| Mar 31, 2018 | -16.47% |
| Dec 31, 2017 | -19.70% |
| Sep 30, 2017 | -21.11% |
| Jun 30, 2017 | -0.74% |
| Mar 31, 2017 | -2.28% |
| Dec 31, 2016 | 5.39% |
| Sep 30, 2016 | 0.84% |
| Jun 30, 2016 | -4.36% |
| Mar 31, 2016 | -7.20% |
| Dec 31, 2015 | 10.47% |
| Sep 30, 2015 | 4.70% |
| Jun 30, 2015 | 0.92% |